Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.9%

10 terminated/withdrawn out of 170 trials

Success Rate

89.5%

+3.0% vs industry average

Late-Stage Pipeline

8%

13 trials in Phase 3/4

Results Transparency

1%

1 of 85 completed trials have results

Key Signals

36 recruiting1 with results5 withdrawn

Enrollment Performance

Analytics

N/A
72(71.3%)
Phase 1
10(9.9%)
Phase 3
9(8.9%)
Phase 2
6(5.9%)
Phase 4
4(4.0%)
101Total
N/A(72)
Phase 1(10)
Phase 3(9)
Phase 2(6)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (170)

Showing 20 of 170 trials
NCT06691087Not ApplicableRecruiting

Sound Perception Study of Hearing-impaired People With Hearing Aids

Role: lead

NCT01520597Completed

National Study on Listeriosis and Listeria

Role: collaborator

NCT07174648Not Yet Recruiting

Testing of a New Rapid Antigen Test for Plague in Ituri, Democratic Republic of the Congo.

Role: collaborator

NCT06923592Phase 3Recruiting

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Role: collaborator

NCT07205913Not Yet Recruiting

Gut Microbiota, Diet-INDuced Obesity and Type 2 Diabetes in New Caledonia - MIND

Role: lead

NCT07388979Not Yet Recruiting

MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo

Role: collaborator

NCT05328037Completed

Study on the Association Between Vitamin C Deficiency and Diarrhea in Children

Role: lead

NCT07170748Recruiting

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

Role: collaborator

NCT07358910Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Role: collaborator

NCT05202288Phase 2Not Yet Recruiting

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Role: collaborator

NCT07291193Not Yet Recruiting

Impact of Sex Hormones on Human Skin Immunity in Health and Hidradenitis Suppurativa (SIAP)

Role: lead

NCT04355533Not ApplicableCompleted

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Role: collaborator

NCT07311213Not ApplicableNot Yet Recruiting

GENES AND AUTISM - IPSC

Role: collaborator

NCT04750720Not ApplicableCompleted

Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection

Role: collaborator

NCT07303413Not ApplicableNot Yet Recruiting

A Rhythmic and Auditory Approach for Children With Autism Spectrum Disorders (ASD)

Role: lead

NCT05220241Not ApplicableCompleted

Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19

Role: collaborator

NCT06694766Not ApplicableRecruiting

VAC-SIP-YF (Vaccination- Safety & Immunogenicity During Pregnancy- Yellow Fever)

Role: lead

NCT07097480Not ApplicableRecruiting

Virus Transmission to People Recently Bitten or With a History of Monkey Bites "SIMVIR

Role: lead

NCT06738563Recruiting

Impact of Breast Milk on the Infectivity and Transmission of Different Viruses "BREASTMILKVIR"

Role: lead

NCT01089400Completed

Immuno-virological Characterization of Severe H1N1v Influenza Infection in Bronchoalveolar Lavage

Role: collaborator